Aapm 108
The 0. As a result, barrier shielding may be required in floors and ceilings as well as adjacent walls.
Mark T. Madsen, Jon A. Anderson, James R. Halama, Jeff Kleck, Douglas J. Simpkin, John R. Votaw, Richard E. Wendt, Lawrence E.
Aapm 108
The 0. As a result, barrier shielding may be required in floors and ceilings as well as adjacent walls. Since the patient becomes the radioactive source after the radiopharmaceutical has been administered, one has to consider the entire time that the subject remains in the clinic. Information about the physical properties of the most commonly used clinical PET radionuclides is summarized, although the report primarily refers to fluorine Typical PET imaging protocols are reviewed and exposure rates from patients are estimated including self-attenuation by body tissues and physical decay of the radionuclide. Examples of barrier calculations are presented for controlled and noncontrolled areas. Shielding for adjacent rooms with scintillation cameras is also discussed. Tables and graphs of estimated transmission factors for lead, steel, and concrete at 0. Meeting the regulatory limits for uncontrolled areas can be an expensive proposition. Careful planning with the equipment vendor, facility architect, and a qualified medical physicist is necessary to produce a cost effective design while maintaining radiation safety standards.
Shielding for adjacent rooms with scintillation cameras is also discussed. Halama, Jeff Kleck, Douglas J.
Calculated shielding requirements may be conservative in some areas when assuming a static point source and absence of scanner self-shielding. Dosimeters were also placed at three positions in the ceiling along the axial length of the scanner. Each position contained three dosimeters covered with 0, 1. Dosimeters were switched out every month for a total collection period of 10 months. The dosimeter measurements were compared to TG estimates by dividing the measured dose by the TG calculated dose.
AAPM is a scientific, educational, and professional nonprofit organization devoted to the discipline of physics in medicine. The information provided in this website is offered for the benefit of its members and the general public, however, AAPM does not independently verify or substantiate the information provided on other websites that may be linked to this site. Encrypted Login. Report No. The 0. As a result, barrier shielding may be required in floors and ceilings as well as adjacent walls. Since the patient becomes the radioactive source after the radiopharmaceutical has been administered, one has to consider the entire time that the subject remains in the clinic.
Aapm 108
The 0. As a result, barrier shielding may be required in floors and ceilings as well as adjacent walls. Since the patient becomes the radioactive source after the radiopharmaceutical has been administered, one has to consider the entire time that the subject remains in the clinic. Information about the physical properties of the most commonly used clinical PET radionuclides is summarized, although the report primarily refers to fluorine Typical PET imaging protocols are reviewed and exposure rates from patients are estimated including self-attenuation by body tissues and physical decay of the radionuclide.
Lenovo keyboard backlight not working
Other availability. Information about the physical properties of the most commonly used clinical PET radionuclides is summarized, although the report primarily refers to fluorine Copy to clipboard. Information about the physical properties of the most commonly used clinical PET radionuclides is summarized, although the report primarily refers to fluorine Halama , Jeff Kleck , Douglas J. Madsen, Mark T. Results: The PET gantry provided considerable shielding in the transaxial detector plane resulting in a low measured to calculated dose ratio of 0. United States: N. Full Record Other Related Research. Careful consideration of the shielding properties of the scanner can reduce the amount of shielding necessary to include in walls.
.
Since the patient becomes the radioactive source after the radiopharmaceutical has been administered, one has to consider the entire time that the subject remains in the clinic. Link to publication in Scopus. Tables and graphs of estimated trans- mission factors for lead, steel, and concrete at 0. Since the patient becomes the radioactive source after the radiopharmaceutical has been administered, one has to consider the entire time that the subject remains in the clinic. AU - Yester, Michael V. Examples of barrier calculations are presented for controlled and noncontrolled areas. As a result, barrier shielding may be required in floors and ceilings as well as adjacent walls. AU - Anderson, Jon A. Similar records in OSTI. Anderson, James R. Anderson , James R. Typical PET imaging protocols are reviewed and exposure rates from patients are estimated including self-attenuation by body tissues and physical decay of the radionuclide.
0 thoughts on “Aapm 108”